Heart failure & cardiomyopathies

Clinical Impact of Follow-Up Endomyocardial Biopsy in Myocarditis During or After Immune-Suppressive Therapy

ESC Heart FailPublished retrospective cohort

Authors' conclusion

One-fourth of EMB-proven myocarditis patients had a clinical indication to repeat EMB at least once during long-term follow-up. Follow-up EMB was safe in all cases; it showed active or borderline myocarditis in 55% of patients and lead to a change in management in the majority of patients.

Study context

Population
Patients with virus-negative endomyocardial biopsy (EMB)-proven myocarditis treated with IMT22 received at least one follow-up EMB
Participants
92 patients
Exposure
Patients receiving follow-up EMB vs those not receiving it
  • Follow-up EMBn = 22
Outcome
Indication for follow-up EMB

Main finding

As reported in the abstract

Clinical worsening

n = 12

Suspected myocarditis relapse

n = 7

To assess IMT response

n = 3

Observational data: associations, not effects.

Further findings

Characteristics of patients receiving follow-up EMB · at diagnosis

More likely abnormal troponin levels
P = 0.048
Trend towards lower prevalence of anti-heart auto-antibodies positivity
P = 0.05
Worse imaging findings at follow-up

Findings on follow-up EMB and management change

Active or borderline myocarditis on follow-up EMB
12 patients
Change in IMT regimen among those with active or borderline myocarditis
10 (83%)
Among patients with healed myocarditis: change in IMT regimen
2
Among patients with healed myocarditis: heart transplant evaluation check list
2
Among patients with healed myocarditis: mitral valve treatment
2
Among patients with healed myocarditis: ventricular tachycardia ablation
1
Among patients with healed myocarditis: primary prevention implantable cardioverter-defibrillator implantation
1

Original publication

Clinical Impact of Follow-Up Endomyocardial Biopsy in Myocarditis During or After Immune-Suppressive Therapy. ESC Heart Fail. Published 30 June 2025. doi:10.1002/ehf2.15349

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.